Back to User profile » Dr Chenyue Zhang
Papers published by Dr Chenyue Zhang:
Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
Zhang C, Shang X, Sun J, Li Z, Lin J, Zhao C, Wang H
International Journal of General Medicine 2021, 14:6899-6906
Published Date: 18 October 2021
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
Ning Z, Zhu Z, Wang H, Zhang C, Xu L, Zhuang L, Yan X, Wang D, Wang P, Meng Z
OncoTargets and Therapy 2019, 12:1161-1170
Published Date: 12 February 2019
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients
Ning Z, Xie J, Chen Q, Zhang C, Xu L, Song L, Meng Z
OncoTargets and Therapy 2019, 12:1021-1029
Published Date: 1 February 2019
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
Zhu Z, Xu L, Zhuang L, Ning Z, Zhang C, Yan X, Lin J, Shen Y, Wang P, Meng Z
OncoTargets and Therapy 2018, 11:6731-6740
Published Date: 10 October 2018
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016